Lisata Therapeutics Inc (LSTA)

[lunatick]

Caladrius Biosciences and Sanford Research Establish Strategic Collaboration With Goal of Developing Major Advance in Treatment of Type 1 Diabetes
Globe Newswire
September 22, 2015: 07:30 AM ET

"BASKING RIDGE, N.J., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. ("Caladrius" or the "Company") (NASDAQ:CLBS), a cell therapy company combining an industry-leading external development and manufacturing provider (PCT) with a development pipeline in immunotherapy, announced today that it has entered into a collaboration agreement with Sanford Research ("Sanford") to develop the Company's T regulatory cell therapy product candidate CLBS03 for the treatment of adolescents with recent-onset type 1 diabetes (T1D). The initial focus of the collaboration will be the execution of a prospective, randomized, placebo-controlled, double-blind clinical trial to evaluate the safety and efficacy of CLBS03 in adolescents. The Phase 2 study (The Sanford Project Trutina Study) has an open and active IND and subject enrollment is expected to commence as early as the first quarter of 2016. ..."

full article:
http://money.cnn.com/news/newsfeeds/articles/globenewswire/10150070.htm